Milan R. Amin

About

Milan R. Amin, MD, is a professor in the Department of Otolaryngology-Head and Neck Surgery at NYU Grossman School of Medicine. He specializes in treating voice, swallowing, and upper airway disorders, serving as the director of NYU Langone’s Voice Center, which brings together physicians, speech pathologists, and other specialists to improve the lives of patients with these conditions. Dr. Amin is known for his expertise in in-office laryngeal surgery, having performed over 250 laryngeal surgeries annually, and is dedicated to providing compassionate care and rehabilitation to help patients return to their activities and professions. He has been recognized as one of the top physicians in voice disorders and laryngology in the United States, being named in Castle Connolly’s “Top Doctors” series for the New York Metro Area and in New York Magazine’s “Best Doctors in New York” issue. In addition to his clinical work, Dr. Amin actively participates in research, having published more than 70 articles on voice disorders and laryngology, contributing to the advancement of treatment outcomes in his field.

Research topics

• Medicine
• Internal medicine
• Physical therapy
• Surgery
• Demography

Selected publications

• Long-term intubation and high rate of tracheostomy in COVID-19 patients might determine an unprecedented increase of airway stenoses: a call to action from the European Laryngological Society

  European Archives of Oto-Rhino-Laryngology · 2020-06-06 · 204 citations

  reviewOpen access

  INTRODUCTION: The novel Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, may need intensive care unit (ICU) admission in up to 12% of all positive cases for massive interstitial pneumonia, with possible long-term endotracheal intubation for mechanical ventilation and subsequent tracheostomy. The most common airway-related complications of such ICU maneuvers are laryngotracheal granulomas, webs, stenosis, malacia and, less commonly, tracheal necr…

  PublisherOA PDFDOI

• The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The <scp>IFOS</scp> Consensus

  The Laryngoscope · 2023 · 119 citations

  OBJECTIVE: The objective of this work was to gather an international consensus group to propose a global definition and diagnostic approach of laryngopharyngeal reflux (LPR) to guide primary care and specialist physicians in the management of LPR. METHODS: Forty-eight international experts (otolaryngologists, gastroenterologists, surgeons, and physiologists) were included in a modified Delphi process to revise 48 statements about definition, clinical presentation, and diagnostic approaches to LP…

  PublisherOA PDFDOI

• Early Outcomes From Early Tracheostomy for Patients With COVID-19

  JAMA Otolaryngology–Head & Neck Surgery · 2020-12-18 · 104 citations

  articleOpen accessSenior author

  Importance: Decision-making in the timing of tracheostomy in patients with coronavirus disease 2019 (COVID-19) has centered on the intersection of long-standing debates on the benefits of early vs late tracheostomy, assumptions about timelines of infectivity of the novel coronavirus, and concern over risk to surgeons performing tracheostomy. Multiple consensus guidelines recommend avoiding or delaying tracheostomy, without evidence to indicate anticipated improvement in outcomes as a result. Obj…

  PublisherOA PDFDOI

• Oropharyngeal Dysphagia in the Elderly: Evaluation and Prevalence

  Current Otorhinolaryngology Reports · 2020-01-17 · 50 citations

  articleSenior author
  PublisherDOI

• DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

  Nature Communications · 2025-02-12 · 13 citations

  articleOpen access

  Recurrent respiratory papillomatosis (RRP) is a chronic airway disease caused by Human Papillomavirus (HPV). INO-3107, DNA immunotherapy designed to elicit T-cells against HPV-6 and HPV-11, was evaluated in a 52-week Phase 1/2 study for efficacy, safety, and immunogenicity (NCT04398433). Thirty-two eligible adults with HPV-6 and/or HPV-11 RRP, requiring ≥2 surgical interventions in the year preceding dosing were enrolled between October 2020 and November 2021 and administered 4 INO-3107 doses by…

  PublisherOA PDFDOI

Frequent coauthors

• Ryan C. Branski

  New York University

  76 shared

• Gregory N. Postma

  Augusta University

  42 shared

• Peter C. Belafsky

  40 shared

• Gregory R. Dion

  University of Cincinnati

  33 shared

• Albert L. Meratı

  University of Washington Medical Center

  21 shared

• Clark A. Rosen

  University of California, San Francisco

  19 shared

• Pavan S. Mallur

  Harvard University

  18 shared

• Yixin Fang

  AbbVie (United States)

  17 shared

Awards & honors

• Honored as one of the top physicians in voice disorders and…
• Named in Castle Connolly’s “Top Doctors” series for the New…
• Named in New York Magazine’s “Best Doctors in New York” issu…

Similar researchers at New York University

• Umamaheswar Duvvurih-67
• Richard A. Lebowitzh-32